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Thyroid hormones influence brain development through the control of gene expression. The
concentration of the active hormone T3 in the brain depends on T3 transport through the blood-
brain barrier,mediated in part by themonocarboxylate transporter 8 (Mct8/MCT8) and the activity
of type 2 deiodinase (D2) generating T3 fromT4. The relative roles of each of these pathways in the
regulation of brain gene expression is not known. To shed light on this question, we analyzed
thyroid hormone-dependent gene expression in the cerebral cortex ofmice with inactivatedMct8
(Slc16a2) and Dio2 genes, alone or in combination. We used 34 target genes identified to be
controlledby thyroidhormone inmicroarray comparisonsof cerebral cortex fromwild-typecontrol
and hypothyroid mice on postnatal d 21. Inactivation of the Mct8 gene (Mct8KO) was without
effect on the expression of 31 of these genes. Normal gene expression in the absence of the
transporter was mostly due to D2 activity because the combined disruption ofMct8 and Dio2 led
to similar effects as hypothyroidism on the expression of 24 genes. Dio2 disruption alone did not
affect the expression of positively regulated genes, but, as in hypothyroidism, it increased that of
negatively regulated genes. We conclude that gene expression in the Mct8KO cerebral cortex is
compensated in part by D2-dependent mechanisms. Intriguingly, positive or negative regulation
of genes by thyroid hormone is sensitive to the source of T3 because Dio2 inactivation selectively
affects the expression of negatively regulated genes. (Endocrinology 151: 2381–2387, 2010)
The effects of thyroid hormones on brain developmentare the result of their complex and intricate action on
the expression of many genes. Thyroid hormone regula-
tion of gene expression in brain has different profiles that
are characteristic of specific developmental stages and
brain regions (1). In addition, the concentration of the
active hormone T3 in brain is controlled by two local
mechanisms.One is the rate of entry fromblood into brain
through specific T4 and T3 transporters located in the
blood-brain barrier and the plasma membrane of neural
cells (2). The second mechanism is the local control of T3
concentration by the deiodinases type 2 (D2) and type 3,
which regulate thebalancebetween itsproduction fromT4
and its degradation to 3,3-diiodothyronine (3). Exami-
nation of brain gene expression inmice with disruption of
theDio2 gene led to the conclusion that the T3 generated
fromD2maynotbe equivalent to theT3 reaching thebrain
from the circulation (4).
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The importance of the transporters is best illustrated by
the severe phenotype caused by mutations of the specific
T4 and T3 transporter MCT8 (monocarboxylate trans-
porter 8, SlC16A2) gene (5). Patients suffer from a severe
neurodevelopmental defect and abnormal distribution
and metabolism of thyroid hormones (2, 6–9). It is as-
sumed that the neurological syndrome is the consequence
of restricted access of T3 to the target neurons (10). Dis-
ruption of theMct8 gene in mice (Mct8KO) also impairs
thyroid hormone uptake in brain and results in changes in
the serum thyroid hormone profile characteristic of hu-
mans withMCT8mutations. Manifestations of brain hy-
pothyroidism include a decrease in brain T3 content, in-
creased brain D2 activity, increased TRH mRNA in the
paraventricular nucleus, and decreased expression of T3
target genes, neurogranin (Nrgn) and Hairless (Hr) (9,
11–13).However structural and functional defects caused
by hypothyroidism in the brain of these animals are min-
imal. Therefore, efficient compensating mechanisms for
the lack of Mct8 must exist in the mouse brain to permit
seemingly normal development.
A likely compensating mechanism for the lack ofMct8
involves the elevatedD2 activity. In the brain parenchima,
D2 is expressed primarily in astrocytes (14–16), and its
activity is elevated in the settings of hypothyroidism and
iodine deficiency, and this helps to maintain the brain T3
content within a safe range provided that there is enough
T4 substrate (3). In Mct8KO mice, the transport of T4
through the blood-brain barrier is less compromised than
that of T3, due to the presence of transporters such as the
organic anion transporter polypeptide 14 (Oatp14,
Slco1c1) (17, 18) with higher affinity for T4 than for T3.
Therefore, it is likely that, due to the elevated level of D2
activity, the T4 that enters the Mct8KO mouse brain is
converted with increased efficiency to T3, with the result
that the brain T3 content is adequate for development.
Despite the importance of D2 for the local generation
of T3, D2-deficient mice (D2KO) also exhibit little evi-
dence of impaired neurofunction, suggesting that enough
T3 is reaching the brain through the blood-brain barrier to
prevent significant brain damage. It was therefore surpris-
ing that D2KO mice and hypothyroid mice have a com-
parable reduction in their brain T3 content but target gene
expression in theD2KOmicewasonlymildly affectedand
certainly not to the same degree as that in the hypothyroid
mice (4). This indicates that the overall content of tissueT3
does not reflect actualT3 action at the cell level because the
latter depends on its presence at specific sites and cells.
Furthermore, inhypothyroidmice,muchof theT3 inbrain
is likely to derive locally fromT4, whereas inD2KOmice,
it must be obtained directly from the circulation because
deiodinase type 1 activity in brain is very low or absent.
Thus, the finding that, compared with the hypothyroid
mouse, gene expression levels are only minimally affected
in the brain of theD2KOmouse suggests that T3 action in
brain may be dependent in part on its source. Therefore,
the different effects on brain gene expression between hy-
pothyroid andD2KOmice suggest differences in the final
effect of T3 from the blood and that from the astrocytes.
In this work, we analyzed the roles of Mct8 as a trans-
porter of T4 and T3 into the brain and D2 in providing
local T3 by studying gene expression in the cerebral cortex
of postnatal mice. First we identified genes that were in-
creased or decreased by hypothyroidism, and therefore
negatively or positively regulated by thyroid hormones.
Thenwe studied the effects of thyroid hormone deficiency
and the lack of functional Mct8 and/or D2. The results
indicate that, in the absence of Mct8, the expression level
of most genes is maintained due at least in part to the T3
generated locallybyD2.On theotherhand, in theabsenceof
D2, the expression levels of thepositive genes aremaintained
solely byT3 obtained from theblood.However, the negative
genes are sensitive to D2 deficiency, suggesting that they are
dependent on the T3 formed locally from T4 by the D2.
Materials and Methods
Animals
Protocols for animal handling were approved by the local
institutional Animal Care Committee, following the rules of the
European Union. Animals were housed in temperature (22  2
C)- and light (12-h light, 12-h dark cycle; lights on at 0700 h)-
controlled conditions and had free access to food and water.
Mct8KO (male genotype, Mct8/y) mice were generated by
Dumitrescu et al. (13) using homologous recombination. Exper-
iments were carried out on wild-type (Wt) and knockout (KO)
male litter mates derived from backcrossing of heterozygous fe-
males with Wt males of the C57BL/6J strain. Genotypes were
confirmed by PCR of tail DNA (38 cycles at 55 C annealing
temperature) using the following primers: forward common, 5-
ACAACAAAAAGCCAAGCATT-3; reverse Wt specific, 5-
GAGAGCAGCGTAAGGACAAA-3; reverse KO specific,
5-CTCCCAAGCCTGATTTCTAT-3. Using this procedure
theWt allele generated a 476-bp PCR product and the null allele
a 239-bp product.
After crossingwithWtmalemice,Mct8KO heterozygous preg-
nantdamsweregiveneitherdrinkingwaterora solutioncontaining
0.02% 1-methyl-2-mercapto-imidazol (Sigma Chemical Co., St.
Louis, MO) plus 1% KClO4 ad libitum. These antithyroid
drugs were given from gestational d 17, and throughout the
lactating period, until the end of the experiment on postnatal
day (P) 21. The pups were genotyped at P11 to select for
Mct8/y andMct8/y mice from the same litters. For simplic-
ity, throughout this paper, these animals will be referred to as
wild-type (Wt) and Mct8KO mice, or the corresponding hy-
pothyroid mice (WtH and Mct8KOH).
Mice deficient in D2 (D2KO; genotype Dio2/) and
mice deficient in both D2 and Mct8 (Mct8D2KO; genotype
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D2/Mct8/y) were generated by crossing D1D2KO with
Wt andMct8KOmice (13). Disruption of theMct8 gene in the
context of D2 deficiency decreased the total brain content of
T3 from 0.75 0.08 ng in theD2KO to 0.10 0.04 ng in the
adult double KO (P  0.001), i.e. only about 7% the normal
content of T3 (4). To produce the male mice used in the ex-
periments, female D2/Mct8/ mice were mated with male
D2/Mct8/y mice, producing D2/Mct8/y (D2KO) and
D2/Mct8/y (Mct8D2KO)male littermates.TheD2genotype
was confirmed by PCR of tail DNA (38 cycles at 57 C annealing
temperature) using the following primers: forward common, 5-
ATTTTCTCTTGACCATCCTT-3; reverse Wt specific, 5-
TATACCAACAGGAAGTCAGC-3; reverse KO specific,
5-GAACTTCCTGACTAGGGGAG-3. This procedure gener-
ateda463-bp fragment fromtheWtallele anda230-bp fragment
from the null allele.
Real-time quantitative PCR (qPCR)
The pups were killed by decapitation on P21. The cerebral
cortex was rapidly dissected out, frozen on dry ice, and kept at
80 C until RNA isolation. The Trizol procedure (Invitrogen,
Carlsbad, CA) was followed, with an additional step of chloro-
form extraction. The quality of RNA was analyzed using a Bio-
Analyzer (Agilent, Santa Clara, CA). cDNA was prepared from
250 ng of RNA using the high-capacity cDNA reverse transcrip-
tionkit (AppliedBiosystems, FosterCity,CA). qPCRassayswere
performedonTaqMan low-density arrays (AppliedBiosystems),
format 98a (P/N 4342253). cDNA aliquots corresponding to 10
ng of starting RNA from individual mice were used, with Taq-
Man universal PCR master mix, No Amp Erase UNG (Applied
Biosystems) on a 7900HT fast real-time PCR system (Applied
Biosystems). The PCR program consisted in a hot start of 95 C
for 10 min, followed by 40 cycles of 15 sec at 95 C and 1 min at
60 C. For analysis we used the 2-Ct method. As internal control
we included 18S RNA, and three negative controls,Diablo [dia-
blo homolog (Drosophila)], Ube2b (ubiquitin-conjugating en-
zyme E2B, RAD6 homology [S. cerevisiae)]6, and Ppia (pepti-
dylprolyl isomerase A). Data were expressed relative to the
values obtained for the control Wt, which was given a value of
1.0 after correction for 18S RNA. Differences between means
were obtained by one- or two-way ANOVA, depending on the
experiment, and the Tukey or Bonferroni’s post hoc tests, re-
spectively. Calculations were done using the GraphPad Prism
software (http://www.graphpad.com/prism/).
Results
The goal of this work was to analyze the role of Mct8 as
a T3 transporter to the brain and that of D2, which gen-
erates T3 from T4 locally, on the regulation of thyroid
hormone-dependent gene expression in the cerebral cor-
tex. To isolate candidate genes for these experiments, we
first performedmicroarray analysis using cerebral cortices
from control and hypothyroid Wt mice (the procedures
and results of this analysis can be found in Supplemental
Materials and Methods and Supplemental Table 1 pub-
lishedonTheEndocrineSociety’s JournalsOnlineweb site
at http://endo.endojournals.org). We found that 316
genes were decreased, and 318 genes increased in the hy-
pothyroid mice and therefore represent genes that are pu-
tatively up- or down-regulated, respectively, by thyroid
hormone. For simplicity we will refer to these two cate-
gories as positive and negative genes, respectively.
Nineteen positive and 15 negative (a total of 34) genes
were used for further analysis. We first selected known
targets of thyroidhormone, suchasHr, Itih3,Nefh,Nefm,
and Sema7a. The restwere chosen following the criteria of
fold change and relative abundance as explained in Sup-
plemental Materials and Methods. We also crossed our
data with the transcriptome database published by Cahoy
et al. (14) to identify specific cell type-enriched genes.
Seven of the selected genes were enriched at least 5-fold in
astrocytes (Aldh1a1, Abcd2, Itga7, Slc1a3, Hapln1,
Sult1a1, and Mamdc2), and four genes were enriched
more than 5-fold in neurons (Nefm, Nefh, Ppm2c, and
Dgkg). The restwas not enriched in any particular cellular
subset.
Effect of thyroid hormone deprivation and the
role of Mct8
This experiment confirmed that the expression of the
selected genes was dependent on the thyroid status and
examined the effect of Mct8 deficiency. To this end we
analyzed by qPCR four groups of animals: Wt and
Mct8KO littermates andWtHandMct8KOHlittermates,
obtained from different dams from those used for the ar-
rays. Figure 1 shows the effects of hypothyroidism and
Mct8deficiency on the expressionof the 19positive genes.
Of the 19 genes, only Cbr2 and Hr were also sensitive to
Mct8 deficiency. The rest had normal expression in the
untreatedMct8KO mice. All were also decreased signifi-
cantly in theMct8KOHmice comparedwith theMct8KO
mice, with the exception of Scube1, in which the decrease
was not significant. Figure 2 shows the results for the 15
negative genes. Expression of all these geneswas increased
in the WtH mice but, with the exception of Dgkg, was
unchanged in the Mct8KO. Hypothyroidism also in-
creased their expression in the Mct8KO with the excep-
tion of Dgkg. The conclusion from these experiments is
that the expression of most thyroid hormone-dependent
genes in the neocortex of the Mct8-deficient mice is kept
normal despite the restriction for T3 entry into the brain.
Role of D2
A second experiment was designed to analyze whether
the normal expression of thyroid hormone-regulated
genes inMct8KOwas due to compensatory generation of
T3 byD2 because an increase in D2 activity has been dem-
onstrated in these mice (9, 13). Four groups of animals
were studied: Wt, Mct8KO, D2KO (genotype Dio2/)
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(4), and Mct8D2KO (genotype Mct8/yDio2/). Com-
parisons betweenWt andMct8KO gave similar results as
shown above for both positive and negative genes. The
single exception was Dgkg, which showed no changes in
this experiment for unknown reasons. For the positive
genes (Fig. 3), isolated D2 deficiency was without effect
compared with theWt animals on most genes studied ex-
cept for Rbm3. Cntn2 and Ppm2c were also decreased in
D2KOmice, but the differencewas borderline significant.
The combined effect ofMct8 andD2deficiency resulted in
the decreased expression of 11 genes (Cbr2, Hr, Cntn2,
Ppm2c, Rbm3, Ier5, Sema7a, Stac2, Nefh, Nefm, and
Scube1) and was without effect on eight genes (Luzp1,
which was borderline significant,Aldh1a1,Abcd2, Itga7,
Itih3, Paqr6, Afap1l1, and Stard4).
Expression of the negative genes was increased in the
D2KO animals with the exception of Slc16a1,Mamdc2,
andHapln1 (Fig. 4). Deficiency of bothMct8 and D2 had
the same effect as D2 deficiency alone except that the in-
crease for Slc1a3, Syce, and Stk22sl did not reach statis-
tical significance.
The above data suggest that there is a significant dif-
ference in the pattern of regulation between the positive
and negative genes. To substantiate this concept, we
pooled all raw data from each group and performed one-
way ANOVA. For the positive genes there was a signifi-
cant effect of genotype [F (2,168)  37.93, P  0.0001]
with a significant difference between the Wt and the
Mct8D2KO mice but not between Wt and the Mct8KO
FIG. 1. Effects of Mct8 deficiency and thyroid hormone deprivation on
gene expression in the cerebral cortex: positive genes. Gene expression
was measured by PCR on TaqMan arrays, using RNAs from control
wild-type mice (Wt), hypothyroid Wt mice (WtH), Mct8/y mice
(Mct8KO), and hypothyroid Mct8/y mice (Mct8KOH) (n  6 for all
groups). Results are expressed as mean  SEM relative to the control
Wt value set as 1.0. Significant differences (*, P  0.05, **, P  0.01,
***, P  0.001) between means were determined by two-way
ANOVA, the two factors being genotype and thyroid status. Abcd2,
ATP-binding cassette, subfamily D (ALD), member 2; Afap1l1, actin
filament-associated protein 1-like 1; Aldh1a1, aldehyde dehydrogenase
family 1; Cbr2, carbonyl reductase 2; Cntn2, contactin 2 (axonal); Hr,
hairless; Ier5, immediate early response 5; Itga7, integrin-7; Itih3,
inter--trypsin inhibitor, heavy chain 3; Luzp1, leucine zipper protein 1;
Nefh, neurofilament, heavy polypeptide; Nefm, neurofilament,
medium polypeptide; Paqr6, progestin and adipoQ receptor family
member VI; Ppm2c, protein phosphatase 2C, magnesium-dependent,
catalytic subunit; Rbm3, RNA binding motif protein-3; Scube1, signal
peptide, CUB domain, EGF-like 1; Sema7a, sema domain,
immunoglobulin domain (Ig), and GPI membrane anchor, (semaphorin)
7A; Stac2, SH3 and cysteine-rich domain 2; Stard4, StAR-related lipid
transfer (START) domain containing 4.
FIG. 2. Effects of Mct8 deficiency and thyroid hormone deprivation on
gene expression in the cerebral cortex: negative genes. Gene expression
was measured by PCR on TaqMan arrays, using RNAs from controlWt
mice, hypothyroidWtmice (WtH),Mct8/y mice (Mct8KO), and
hypothyroidMct8/y mice (Mct8KOH) (n 6 for all groups). Results are
expressed as mean  SEM relative to the control Wt value set as 1.0.
Significant differences (*, P  0.05; **, P  0.01; ***, P  0.001)
between means were determined by two-way ANOVA, the two factors
being genotype and thyroid status. Agbl3, ATP/GTP binding protein-
like 3; Cirbp, cold inducible RNA binding protein; Col6a1, collagen,
type VI, 1. Dgkg, diacylglycerol kinase, ; Hapln1, hyaluronan and
proteoglycan link protein 1; Icosl, Icos ligand; Mamdc2, MAM domain
containing 2; Marcksl1, MARCKS-like 1; Odf4, outer dense fiber of
sperm tails 4; Pcsk4, proprotein convertase subtilisin/kexin type 4;
Slc1a3, solute carrier family 1 (glial high affinity glutamate
transporter), member 3; Slc16a1, solute carrier family 16, member 1
(monocarboxylic acid transporter 1); Stk22s1, serine/threonine kinase
22 substrate 1; Sult1a1, sulfotransferase family, cytosolic, 1A, phenol-
preferring, member 1; Syce2, synaptonemal complex central element
protein 2.
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andD2KOmice. These data reinforce the observation on
individual genes on the lack of effect of isolatedMct8 and
D2deficiencybut decreased expression in thedeficiencyof
both Mct8 and D2. In other words, adequate generation
ofT3 due to the increased level ofD2 activity compensated
for the defect in T3 transport in Mct8KO mice, and vice
versa, indicating that the positive genes can be regulated
appropriately by T3 from the blood or by T3 generated
from T4 by D2.
For the negative genes, there was also a significant effect
of genotype,withF (2,131)45.00,P0.0001.However, in
contrast to the positive genes, there was a significant differ-
ence between theWt andD2KOmice aswell as between the
Wt and theMct8D2KO mice. The mean expression of the
negative genes in the D2KO mice was not different from
theMct8D2KOmice. This indicates that the negative genes
depend on a normal level of D2 activity to generate the T3
required to maintain a normal level of gene expression.
Discussion
The principal goal of this work was to determine to what
extent blood T3 reaching the mouse brain trough the Mct8
transporter and that generated locally by T4 deiodination
contribute to thehormonal effectongeneexpression.To this
aimweusedMct8- andD2-deficientmice alone and in com-
bination.mRNAs found tobe regulatedby thyroidhormone
weremeasured by qPCR in the cerebral cortex of thesemice.
These mRNAs were identified as being either positively or
negatively regulated by thyroid hormone through a prelim-
inary microarray screen of mRNA from cortices ofWtmice
that were untreated andmice deprived of thyroid hormone.
Previous work has shown that the mRNA levels of two
thyroid hormone target genes, Hr and Nrgn, were de-
creased in the whole brain and cerebellum (Hr) or the
striatum (Nrgn) ofMct8KOmice (9, 11, 13). In thiswork,
we examined whether other thyroid hormone-dependent
genes identified in the P21 mouse cerebral cortex behave
as Nrgn and Hr. The most striking finding is that despite
the reported reduction of brain T3 content, the expression
of thyroid hormone-dependent genes in theMct8KOmice
is generally similar to that in theWtmice, with exceptions
such as Hr and Cbr2.
The lack of significant effect of Mct8 deficiency on the
expression of multiple genes regulated by thyroid hor-
FIG. 3. Effects of D2 deficiency on gene expression in the cerebral
cortex: positive genes. Gene expression was measured by PCR on
TaqMan arrays (microfluidic cards), using RNAs from control Wt mice,
Mct8/y, Mct8/yDio2/ mice (Mct8D2KO), and Dio2/ mice (D2KO)
(n  3 for all groups). Results are expressed as mean SEM relative to
the control Wt value set as 1.0. #, These samples were lost during the
procedure. Significant differences (*, P 0.05; **, P 0.01; ***, P
0.001) between means compared with the control values were
determined by one-way ANOVA. All other comparisons for which the
significance is not shown were not significant. Gene abbreviations as in
Fig. 1.
FIG. 4. Effects of D2 deficiency on gene expression in the cerebral
cortex: negative genes. Gene expression was measured by PCR on
TaqMan arrays (microfluidic cards), using RNAs from control Wt mice,
Mct8/y, Mct8/yDio2/ mice (Mct8D2KO), and Dio2/ mice (D2KO)
(n  3 for all groups). Results are expressed as mean  SEM relative to
the control Wt value set as 1.0. Significant differences (*, P  0.05;
**, P  0.01; ***, P  0.001) between means compared with the
control values were determined by one-way ANOVA. All other
comparisons for which the significance is not shown were not
significant. Gene abbreviations as in Fig. 2.
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mone in mouse cerebrum was somewhat surprising. Yet
previous work indicated that mechanisms exist to com-
pensate for the lack of Mct8 in the mouse brain (11, 18).
One likely mechanism involves D2, which in brain is ex-
pressed primarily in astrocytes (14, 15). D2 activity is in-
creased severalfold in the brain ofMct8-deficient mice. In
the absence of Mct8, transport of T4 is less compromised
than transport of T3 (9, 11). Therefore, enoughT4 reaches
the brain in which due to the elevated level of D2 activity,
sufficientT3, even though still only 50%of that inWtmice
(9, 13), is generated to normalize gene expression.
In fact, further analysis suggests that the T3 generated
locally by the D2 is responsible for the normal expression
of most of the genes studied in Mct8-deficient mice. As
mentioned in theMaterials andMethods, in the combined
Mct8 and D2 deficiency brain T3 content is reduced to a
level that is barely detectable by a highly sensitive RIA. In
this situation 11 of 19 positive genes were decreased, sug-
gesting that D2 is involved in the compensation mecha-
nisms for some but not all of these genes. Themechanisms
for compensation of these genes are unclear and difficult
to explain with the available data, but it is possible that
they are very sensitive to low amounts of T3 that might be
reaching the target cells, even in the combined absence of
Mct8 and D2.
Anotabledifferencewas identifiedbetween thepositive
and negative genes. The formerwere not affected byD2or
Mct8 deficiency alone,whereas the combined defect led to
reduced expression. These genes appear to be regulated
equally well by T3 obtained directly from the blood or by
T3 generated in the cerebral cortex.On the other hand, the
negative genes were not affected by Mct8 deficiency but
were sensitive to D2 deficiency and the combined D2 and
Mct8 deficiency. This result suggests that the negative
genes aremore dependent on the T3 produced locally than
on the T3 obtained directly from the circulation. The hy-
pothesis of dissimilar effects of brainT3derived from these
two sources was also formulated by Galton et al. (4). At
present it is difficult to provide a coherent explanation for
this phenomenon. It may be related to multiple causes.
Most attractive is the notion that the positive and negative
genes have different sensitivity to themagnitude of change
in thyroid hormone. In other words, positive gene regu-
lation can be sustained by lower concentrations of thyroid
hormone derived from the systemic circulation, whereas
negative gene regulation requires a higher concentration
of thyroid hormone achieved by local conversion of T4 to
T3 and uptake from the bloodstream.
Another, although less likely,mechanism is through the
nongenomic action of T4 (19). T4 concentration is higher
inD2KOmice,whichmayhave a yet-unidentified indirect
genomic effect on negative genes. Other factors such as
differences in cellular composition cannot be ruled out.
The dissociation between positive and negative regu-
lation in theD2KOmice is reminiscent of that observed in
some mutations of the Thrb gene (encoding the thyroid
hormone receptor- subtype) leading to central resistance
to thyroid hormone (20, 21). When the mutant thyroid
hormone receptor is expressed inmice, positive regulation
by T3 is preserved, but negative regulation is impaired
(20). This phenomenon seems to be due to the altered
molecular properties of the mutant receptor and selective
impairment of interaction with corepressors. The molec-
ularmechanism for negative regulation of gene expression
by T3 is not clear, involving interactions with corepressor
proteins, decreasedor increasedhistone acetylationwithout
coactivator recruitment (22), and other histone modifica-
tions (21).We can only speculate on how these mechanisms
might be influenced by signaling pathways directly or indi-
rectly related toT4 toT3 conversion in theastrocytes.Clearly
this is an interesting topic for future exploration.
These studies do not intend to explain the differences in
phenotype between patients and mice with transporter
defect. A possible explanation is the presence of alterna-
tive transporters in mice that are not present in humans,
such as Slco1c1 (Oatp14) (18) or Slc7a8 (Lat2) (23). An-
other possibility in light of this work would be differences
in the timing or regional expression of D2 during devel-
opment between human and mice and therefore on the
capacity to compensate for the lack of T3 transport. Com-
pensationmay bemore efficient in some parts of the brain
than in others due to differences in expression between
Mct8 andD2 inparticular regions of the developing brain.
Finally,aspeciesdifference inthequantitativerequirementof
thyroid hormone during development may account for the
psychomotor defect characteristic in humans.
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